The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Targeting Inflammation Driven by HMGB1
Open accessAbstract
High mobility group box 1 (HMGB1) is a highly conserved, nuclear protein present in all cell types. It is a multi-facet protein exerting functions both inside and outside of cells. Extracellular HMGB1 has been extensively studied for its prototypical alarmin functions activating innate immunity, after being actively released from cells or passively released upon cell death. TLR4 and RAGE operate as the main HMGB1 receptors. Disulfide HMGB1 activates the TLR4 complex by binding to MD-2. The binding site is separate from that of LPS and it is now feasible to specifically interrupt HMGB1/TLR4 activation without compromising protective LPS/TLR4-dependent functions. Another important therapeutic strategy is established on the administration of HMGB1 antagonists precluding RAGE-mediated endocytosis of HMGB1 and HMGB1-bound molecules capable of activating intracellular cognate receptors. Here we summarize the role of HMGB1 in inflammation, with a focus on recent findings on its mission as a damage-associated molecular pattern molecule and as a therapeutic target in inflammatory diseases. Recently generated HMGB1-specific inhibitors for treatment of inflammatory conditions are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Yang, H., Lundbäck, P., Ottosson, L., Erlandsson-Harris, H., Venereau, E., Bianchi, M. E., Al-Abed, Y., Andersson, U., Tracey, K. J., & Antoine, D. J. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00389 · Cited by 407
Self-citationRetractedSun, Q., Loughran, P., Shapiro, R. A., Shrivastava, I. H., Antoine, D. J., Li, T., Yan, Z., Fan, J., Billiar, T. R., & Scott, M. J. (2016) · Hepatology · doi:10.1002/hep.28893 · Cited by 40
RetractedThe third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,820
The Pathophysiology and Treatment of Sepsis
Hotchkiss, R. S., & Karl, I. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021333 · Cited by 4,097
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,385
Self-citationYang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358696 · Cited by 3,253
Inflammatory caspases are innate immune receptors for intracellular LPS
Shi, J., Zhao, Y., Wang, Y., Gao, W., Ding, J., Li, P., Hu, L., & Shao, F. (2014) · Nature · doi:10.1038/nature13683 · Cited by 2,285
Noncanonical Inflammasome Activation by Intracellular LPS Independent of TLR4
Kayagaki, N., Wong, M. T., Stowe, I. B., Ramani, S. R., Gonzalez, L. C., Akashi-Takamura, S., Miyake, K., Zhang, J., Lee, W. P., Muszyński, A., et al. (2013) · Science · doi:10.1126/science.1240248 · Cited by 1,545
HMGB1 is a therapeutic target for sterile inflammation and infection
Andersson, U., & Tracey, K. J. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101323 · Cited by 1,437
Self-citationTian, J., Avalos, A. M., Mao, S.-Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S., Golenbock, D., Sirois, C., et al. (2007) · Nature Immunology · doi:10.1038/ni1457 · Cited by 1,372
Cytoplasmic LPS Activates Caspase-11: Implications in TLR4-Independent Endotoxic Shock
Hagar, J. A., Powell, D. A., Aachoui, Y., Ernst, R. K., & Miao, E. A. (2013) · Science · doi:10.1126/science.1240988 · Cited by 1,259
Reversing established sepsis with antagonists of endogenous high-mobility group box 1
Yang, H., Ochani, M., Li, J., Qiang, X., Tanovic, M., Harris, H. E., Susarla, S. M., Ulloa, L., Wang, H., DiRaimo, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2434651100 · Cited by 1,126
Self-citationSepsis: a roadmap for future research
Cohen, J., Vincent, J.-L., Adhikari, N. K. J., Machado, F. R., Angus, D. C., Calandra, T., Jaton, K., Giulieri, S., Delaloye, J., Opal, S., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70112-x · Cited by 992
Kang, R., Chen, R., Zhang, Q., Hou, W., Wu, S., Cao, L., Huang, J., Yu, Y., Fan, X.-G., Yan, Z., et al. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.05.001 · Cited by 956
Self-citationHMGB1 SIGNALS THROUGH TOLL-LIKE RECEPTOR (TLR) 4 AND TLR2
Yu, M., Wang, H., Ding, A., Golenbock, D. T., Latz, E., Czura, C. J., Fenton, M. J., Tracey, K. J., & Yang, H. (2006) · Shock · doi:10.1097/01.shk.0000225404.51320.82 · Cited by 832 · cited 1×
“We thus propose that upon active secretion by innate immune cells or passive release by somatic cells, extracellular HMGB1 binds TLR4 (31) to induce the expression and production of various cytokines and chemokines, but triggers macrophage pyroptosis if it binds to RAGE and is internalized via receptor-mediated endocy…”
BackgroundSelf-citationYang, H., Hreggvidsdottir, H. S., Palmblad, K., Wang, H., Ochani, M., Li, J., Lu, B., Chavan, S., Rosas-Ballina, M., Al-Abed, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003893107 · Cited by 809
Self-citationSplenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia
Rosas-Ballina, M., Ochani, M., Parrish, W. R., Ochani, K., Harris, Y. T., Huston, J. M., Chavan, S., & Tracey, K. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803237105 · Cited by 753
Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release
Venereau, E., Casalgrandi, M., Schiraldi, M., Antoine, D. J., Cattaneo, A., De Marchis, F., Liu, J., Antonelli, A., Preti, A., Raeli, L., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120189 · Cited by 720 · cited 1×
“The fully reduced HMGB1 released extracellularly forms a complex with the chemokine CXCL12 (SDF-1) and initiates enhanced chemotaxis via CXCR4 compared to CXCL12 acting alone (6).”
BackgroundSelf-citationHuston, J. M., Ochani, M., Rosas-Ballina, M., Liao, H., Ochani, K., Pavlov, V. A., Gallowitsch-Puerta, M., Ashok, M., Czura, C. J., Foxwell, B., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052362 · Cited by 683
High-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart
Andrassy, M., Volz, H. C., Igwe, J. C., Funke, B., Eichberger, S. N., Kaya, Z., Buss, S., Autschbach, F., Pleger, S. T., Lukic, I. K., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.769331 · Cited by 620
The Endotoxin Delivery Protein HMGB1 Mediates Caspase-11-Dependent Lethality in Sepsis
Deng, M., Tang, Y., Li, W., Wang, X., Zhang, R., Zhang, X., Zhao, X., Liu, J., Tang, C., Liu, Z., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.08.016 · Cited by 591
Self-citationcGAS senses long and HMGB/TFAM-bound U-turn DNA by forming protein-DNA ladders
Andreeva, L., Hiller, B., Kostrewa, D., Lässig, C., de Oliveira Mann, C. C., Jan Drexler, D., Maiser, A., Gaidt, M., Leonhardt, H., Hornung, V., et al. (2017) · Nature · doi:10.1038/nature23890 · Cited by 511
Sundén-Cullberg, J., Norrby-Teglund, A., Rouhiainen, A., Rauvala, H., Herman, G., Tracey, K. J., Lee, M. L., Andersson, J., Tokics, L., & Treutiger, C. J. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000155991.88802.4d · Cited by 428
The HMGB1 Receptor RAGE Mediates Ischemic Brain Damage
Muhammad, S., Barakat, W., Stoyanov, S., Murikinati, S., Yang, H., Tracey, K. J., Bendszus, M., Rossetti, G., Nawroth, P. P., Bierhaus, A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2435-08.2008 · Cited by 412
Self-citationRole of HMGB1 in apoptosis-mediated sepsis lethality
Qin, S., Wang, H., Yuan, R., Li, H., Ochani, M., Ochani, K., Rosas-Ballina, M., Czura, C. J., Huston, J. M., Miller, E., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052203 · Cited by 400
Self-citationMD-2 is required for disulfide HMGB1–dependent TLR4 signaling
Yang, H., Wang, H., Ju, Z., Ragab, A. A., Lundbäck, P., Long, W., Valdes-Ferrer, S. I., He, M., Pribis, J. P., Li, J., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141318 · Cited by 375
Self-citationLiu, K., Mori, S., Takahashi, H. K., Tomono, Y., Wake, H., Kanke, T., Sato, Y., Hiraga, N., Adachi, N., Yoshino, T., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8770com · Cited by 366
Targeting HMGB1 in inflammation
Yang, H., & Tracey, K. J. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.11.019 · Cited by 351
Self-citationKokkola, R., Li, J., Sundberg, E., Aveberger, A. ‐., Palmblad, K., Yang, H., Tracey, K. J., Andersson, U., & Harris, H. E. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11161 · Cited by 325
Self-citationYang, X., Cheng, X., Tang, Y., Qiu, X., Wang, Y., Kang, H., Wu, J., Wang, Z., Liu, Y., Chen, F., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.11.005 · Cited by 325
Zhang, J., Takahashi, H. K., Liu, K., Wake, H., Liu, R., Maruo, T., Date, I., Yoshino, T., Ohtsuka, A., Mori, S., et al. (2011) · Stroke · doi:10.1161/strokeaha.110.598334 · Cited by 314
High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells
Andersson, U., Yang, H., & Harris, H. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.02.011 · Cited by 309
Self-citationExtracellular HMGB1 as a therapeutic target in inflammatory diseases
Andersson, U., Yang, H., & Harris, H. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1439924 · Cited by 287
Self-citationMacrophage endocytosis of high-mobility group box 1 triggers pyroptosis
Xu, J., Jiang, Y., Wang, J., Shi, X., Liu, Q., Liu, Z., Li, Y., Scott, M. J., Xiao, G., Li, S., et al. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2014.40 · Cited by 239
Anti–high mobility group box‐1 antibody therapy for traumatic brain injury
Okuma, Y., Liu, K., Wake, H., Zhang, J., Maruo, T., Date, I., Yoshino, T., Ohtsuka, A., Otani, N., Tomura, S., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23602 · Cited by 236
Angus, D. C., Yang, L., Kong, L., Kellum, J. A., Delude, R. L., Tracey, K. J., & Weissfeld, L. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000259534.68873.2a · Cited by 210
Proteolytic Cleavage of High Mobility Group Box 1 Protein by Thrombin-Thrombomodulin Complexes
Ito, T., Kawahara, K.-I., Okamoto, K., Yamada, S., Yasuda, M., Imaizumi, H., Nawa, Y., Meng, X., Shrestha, B., Hashiguchi, T., et al. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.150631 · Cited by 206
HMGB1 Mediates Cognitive Impairment in Sepsis Survivors
Chavan, S. S., Huerta, P. T., Robbiati, S., Valdes-Ferrer, S. I., Ochani, M., Dancho, M., Frankfurt, M., Volpe, B. T., Tracey, K. J., & Diamond, B. (2012) · Molecular Medicine · doi:10.2119/molmed.2012.00195 · Cited by 199
Agalave, N. M., Larsson, M., Abdelmoaty, S., Su, J., Baharpoor, A., Lundbäck, P., Palmblad, K., Andersson, U., Harris, H., & Svensson, C. I. (2014) · Pain · doi:10.1016/j.pain.2014.06.007 · Cited by 178
Self-citationCritical role of RAGE and HMGB1 in inflammatory heart disease
Bangert, A., Andrassy, M., Müller, A.-M., Bockstahler, M., Fischer, A., Volz, C. H., Leib, C., Göser, S., Korkmaz-Icöz, S., Zittrich, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522288113 · Cited by 170
Dexmedetomidine Controls Systemic Cytokine Levels through the Cholinergic Anti-inflammatory Pathway
Xiang, H., Hu, B., Li, Z., & Li, J. (2014) · Inflammation · doi:10.1007/s10753-014-9906-1 · Cited by 160
Tsoyi, K., Jang, H. J., Nizamutdinova, I. T., Kim, Y. M., Lee, Y. S., Kim, H. J., Seo, H. G., Lee, J. H., & Chang, K. C. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01126.x · Cited by 158
Huang, Y., Yin, H., Han, J.-Y., Huang, B., Xu, J., Zheng, F., Tan, Z., Fang, M., Rui, L., Chen, D., et al. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01734.x · Cited by 151
Sepsis and disseminated intravascular coagulation
Okamoto, K., Tamura, T., & Sawatsubashi, Y. (2016) · Journal of Intensive Care · doi:10.1186/s40560-016-0149-0 · Cited by 148
Schierbeck, H., Lundbäck, P., Palmblad, K., Klevenvall, L., Erlandsson-Harris, H., Andersson, U., & Ottosson, L. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00264 · Cited by 134
Self-citationIdentification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes
Yang, H., Wang, H., Levine, Y. A., Gunasekaran, M., Wang, Y., Addorisio, M. E., Zhu, S., Li, W., Li, J., de Kleijn, D. P. V., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.85375 · Cited by 125
Self-citationMetformin directly binds the alarmin HMGB1 and inhibits its proinflammatory activity
Horiuchi, T., Sakata, N., Narumi, Y., Kimura, T., Hayashi, T., Nagano, K., Liu, K., Nishibori, M., Tsukita, S., Yamada, T., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.769380 · Cited by 125
Therapeutic potential of an anti-high mobility group box-1 monoclonal antibody in epilepsy
Zhao, J., Wang, Y., Xu, C., Liu, K., Wang, Y., Chen, L., Wu, X., Gao, F., Guo, Y. C., Zhu, J., et al. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.02.002 · Cited by 124
Feldman, P., Due, M. R., Ripsch, M. S., Khanna, R., & White, F. A. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-180 · Cited by 122
Yang, H., Liu, H., Zeng, Q., Imperato, G. H., Addorisio, M. E., Li, J., He, M., Cheng, K. F., Al‐Abed, Y., Harris, H. E., et al. (2019) · Molecular Medicine · doi:10.1186/s10020-019-0081-6 · Cited by 121
Self-citationHMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells
Wild, C. A., Bergmann, C., Fritz, G., Schuler, P. J., Hoffmann, T. K., Lotfi, R., Westendorf, A. M., Brandau, S., & Lang, S. (2012) · International Immunology · doi:10.1093/intimm/dxs051 · Cited by 119
Fu, L., Liu, K., Wake, H., Teshigawara, K., Yoshino, T., Takahashi, H. K., Mori, S., & Nishibori, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-01325-y · Cited by 119
Lundbäck, P., Lea, J. D., Sowińska, A., Ottosson, L., Fürst, C. M., Stéen, J., Aulin, C., Clarke, J. I., Kipar, A., Klevenvall, L., et al. (2016) · Hepatology · doi:10.1002/hep.28736 · Cited by 115
Self-citationAnti-HMGB1 monoclonal antibody therapy for a wide range of CNS and PNS diseases
Nishibori, M., Mori, S., & Takahashi, H. K. (2019) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2019.04.006 · Cited by 108
Wang, D., Liu, K., Wake, H., Teshigawara, K., Mori, S., & Nishibori, M. (2017) · Scientific Reports · doi:10.1038/srep46243 · Cited by 107
Le, K., Chibaatar, E., Wu, S., Qian, F., Ali, A. I., Yu, D., & Guo, Y. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105779 · Cited by 107
Sekiguchi, F., Domoto, R., Nakashima, K., Yamasoba, D., Yamanishi, H., Tsubota, M., Wake, H., Nishibori, M., & Kawabata, A. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.08.040 · Cited by 106
Nakamura, Y., Morioka, N., Abe, H., Zhang, F. F., Hisaoka‐Nakashima, K., Liu, K., Nishibori, M., & Nakata, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073640 · Cited by 96
Zhang, X., Li, W., Wu, Q., Wu, Q., Ye, Z.-N., Liu, J., Zhuang, Z., Zhou, M., Zhang, X., & Hang, C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081331 · Cited by 84
Patel, V., Sitapara, R. A., Gore, A., Phan, B. D., Sharma, L., Sampat, V., Li, J. H., Yang, H., Chavan, S. S., Wang, H., et al. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0279oc · Cited by 82
Self-citationPreconditioning with high mobility group box 1 (HMGB1) induces lipopolysaccharide (LPS) tolerance
Aneja, R. K., Tsung, A., Sjödin, H., Gefter, J. V., Delude, R. L., Billiar, T. R., & Fink, M. P. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0108030 · Cited by 82
Novel strategies for targeting innate immune responses to influenza
Shirey, K. A., Lai, W., Patel, M. C., Pletneva, L. M., Pang, C. J., Kurt‐Jones, E. A., Lipsky, M., Roger, T., Calandra, T., Tracey, K. J., et al. (2016) · Mucosal Immunology · doi:10.1038/mi.2015.141 · Cited by 80
Cai, J., Yuan, H., Wang, Q., Yang, H., Al‐Abed, Y., Zhong, H., Wang, J., Chen, D., Wu, J., Lü, B., et al. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.305789 · Cited by 79
Self-citationGrégoire, M., Tadié, J., Uhel, F., Gacouin, A., Piau, C., Bone, N. B., Tulzo, Y. L., Abraham, E. H., Tarte, K., & Zmijewski, J. W. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.5hi0316-128rr · Cited by 73
Yan, L., Yang, Z., Yin, T., Li, L., Yuan, W., Wu, H., & Wang, C. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.11.014 · Cited by 70
Gong, Q., Xu, J., Yin, H., Liu, S., Duan, L. ‐., & Bian, Z. (2008) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2008.02194.x · Cited by 68
Jiang, H., Duan, J., Xu, K., & Zhang, W. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7594 · Cited by 66
TLR4 Mediates Early Graft Failure After Intraportal Islet Transplantation
Gao, Q., Ma, L. L., Gao, X., Yan, W., Williams, P. J., & Yin, D. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03151.x · Cited by 63
Protective Effect of HMGB1 A Box on Organ Injury of Acute Pancreatitis in Mice
Yuan, H., Jin, X., Sun, J.-B., Li, F., Feng, Q., Zhang, W., Cao, Y., & Wang, Y. (2009) · Pancreas · doi:10.1097/mpa.0b013e31818166b4 · Cited by 61
Han, Y., Yuan, F., Deng, C., He, F., Zhang, Y., Shen, H., Chen, Z., & Qian, L. (2019) · Aging · doi:10.18632/aging.102453 · Cited by 58
Nosaka, N., Yashiro, M., Yamada, M., Fujii, Y., Tsukahara, H., Liu, K., Nishibori, M., Matsukawa, A., & Morishima, T. (2015) · Critical Care · doi:10.1186/s13054-015-0983-9 · Cited by 57
HMGB1 Mediates Anemia of Inflammation in Murine Sepsis Survivors
Valdés‐Ferrer, S. I., Papoin, J., Dancho, M. E., Olofsson, P. S., Li, J., Lipton, J. M. M., Avancena, P., Yang, H., Zou, Y.-R., Chavan, S. S., et al. (2015) · Molecular Medicine · doi:10.2119/molmed.2015.00243 · Cited by 57
Self-citationHisaoka‐Nakashima, K., Tomimura, Y., Yoshii, T., Ohata, K., Takada, N., Zhang, F. F., Nakamura, Y., Liu, K., Wake, H., Nishibori, M., et al. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.02.005 · Cited by 57
Zhang, F. F., Morioka, N., Harano, S., Nakamura, Y., Liu, K., Nishibori, M., Hisaoka‐Nakashima, K., & Nakata, Y. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13434 · Cited by 55
Christaki, E., Opal, S. M., Keith, J. C., Kessimian, N., Palardy, J. E., Parejo, N. A., Tan, X. Y., Piche‐Nicholas, N., Tchistiakova, L., Vlasuk, G. P., et al. (2011) · Shock · doi:10.1097/shk.0b013e31820b2e1c · Cited by 53
Nishida, T., Tsubota, M., Kawaishi, Y., Yamanishi, H., Kamitani, N., Sekiguchi, F., Ishikura, H., Liu, K., Nishibori, M., & Kawabata, A. (2016) · Toxicology · doi:10.1016/j.tox.2016.07.016 · Cited by 53
Otoshi, K., Kikuchi, S., Kato, K., Sekiguchi, M., & Konno, S. (2011) · Spine · doi:10.1097/brs.0b013e3181ecd675 · Cited by 50
Haptoglobin improves shock, lung injury, and survival in canine pneumonia
Remy, K. E., Cortés-Puch, I., Solomon, S. B., Sun, J., Pockros, B. M., Feng, J., Lertora, J. J., Hantgan, R. R., Liu, X., Perlegas, A., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.123013 · Cited by 49
Zi, S., Li, J., Liu, L., Deng, C., Ao, X., Chen, D., & Wu, S.-Z. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105898 · Cited by 49
Late Peaks of HMGB1 and Sepsis Outcome: Evidence For Synergy With Chronic Inflammatory Disorders
Karakike, E., Adami, M., Lada, M., Gkavogianni, T., Koutelidakis, I. M., Bauer, M. W., Giamarellos‐Bourboulis, E. J., & Tsangaris, I. (2018) · Shock · doi:10.1097/shk.0000000000001265 · Cited by 41
Okuma, Y., Wake, H., Teshigawara, K., Takahashi, Y., Hishikawa, T., Yasuhara, T., Mori, S., Takahashi, H. K., Date, I., & Nishibori, M. (2018) · World Neurosurgery · doi:10.1016/j.wneu.2018.10.164 · Cited by 38
Therapeutic Targeting of High-Mobility Group Box-1 in Pulmonary Arterial Hypertension
Goldenberg, N. M., Hu, Y., Hu, X., Volchuk, A., Zhao, Y. D., Kucherenko, M. M., Knosalla, C., de Perrot, M. E., Tracey, K. J., Al‐Abed, Y., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201808-1597le · Cited by 35
Porat, A., Giat, E., Kowal, C., He, M., Son, M., Latz, E., Ben‐Zvi, I., Al‐Abed, Y., & Diamond, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02824 · Cited by 34
High‐Mobility Group Box 1 Inhibition Alleviates Lupus‐Like Disease in BXSB Mice
Zhang, C., Li, C., Jia, S., Yao, P.-B., Yang, Q., & Zhang, Y. (2014) · Scandinavian Journal of Immunology · doi:10.1111/sji.12165 · Cited by 32
Lee, J. D., Liu, N., Levin, S. C., Ottosson, L., Andersson, U., Harris, H. E., & Woodruff, T. M. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1435-2 · Cited by 29
Self-citationSun, S., He, M., Wang, Y., Yang, H., & Al‐Abed, Y. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193028 · Cited by 27
Self-citationHatayama, K., Nosaka, N., Yamada, M., Yashiro, M., Fujii, Y., Tsukahara, H., Liu, K., Nishibori, M., Matsukawa, A., & Morishima, T. (2018) · Journal of Medical Virology · doi:10.1002/jmv.25330 · Cited by 24
Preconditioning With High Mobility Group Box 1 (HMGB1) Induces Lipoteichoic Acid (LTA) Tolerance
Robert, S. M., Sjödin, H., Fink, M. P., & Aneja, R. K. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181dcd111 · Cited by 23
Sequestering HMGB1 via DNA-Conjugated Beads Ameliorates Murine Colitis
Ju, Z., Chavan, S. S., Antoine, D. J., Dancho, M. E., Tsaava, T., Li, J., Lü, B., Levine, Y. A., Stiegler, A., Tamari, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103992 · Cited by 23
Self-citationNakajo, M., Uezono, N., Nakashima, H., Wake, H., Komiya, S., Nishibori, M., & Nakashima, K. (2018) · Neuroscience Research · doi:10.1016/j.neures.2018.03.004 · Cited by 22
Treatment with Anti-HMGB1 Monoclonal Antibody Does Not Affect Lupus Nephritis in MRL/lpr Mice
Schaper, F., van Timmeren, M. M., Petersen, A. H., Horst, G., Bijl, M., Limburg, P. C., Westra, J., & Heeringa, P. (2016) · Molecular Medicine · doi:10.2119/molmed.2015.00176 · Cited by 21
Cited by
Yang, K., Fan, M., Wang, X., Xu, J., Wang, Y., Tu, F., Gill, P. S., Ha, T., Liu, L., Williams, D. L., et al. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-021-00841-9 · Cited by 798
DAMPs and DAMP-sensing receptors in inflammation and diseases
Ma, M., Jiang, W., & Zhou, R. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.002 · Cited by 515
Pyroptosis-Induced Inflammation and Tissue Damage
Vasudevan, S. O., Behl, B., & Rathinam, V. A. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101781 · Cited by 412
Pathophysiology of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: A Review
Dodd, W. S., Laurent, D., Dumont, A. S., Hasan, D. M., Jabbour, P. M., Starke, R. M., Hosaka, K., Polifka, A. J., Hoh, B. L., & Chalouhi, N. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.021845 · Cited by 315
Current Challenges and Opportunities of Photodynamic Therapy against Cancer
Huis in ‘t Veld, R. V., Heuts, J., Ma, S., Cruz, L. J., Ossendorp, F. A., & Jager, M. J. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020330 · Cited by 159
Metadata
- Authors
- Yang, H., Wang, H., & Andersson, U.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-03-20
- Volume
- 11
- Pages
- 484-484
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3012314530
- Cited by
- 636
- References
- 92
- FWCI
- 43.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.